SCHEMBL328901

SCHEMBL328901

COC(=O)C12CC3CC(C1)C(N1CC(COc4ccc(-n5ccnc5)cc4)C(C)(C)C1=O)C(C3)C2

nearest known ligand 0.84

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD11B1 P28845 8/20 0.84
HSD11B2 P80365 7/20 0.84
LMNA P02545 4/20 0.38
ALDH1A1 P00352 2/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 1/20 0.38
MAPT P10636 4/20 0.37
HTT P42858 3/20 0.37
TP53 P04637 1/20 0.37
NPSR1 Q6W5P4 2/20 0.36
CYP2D6 P10635 3/20 0.36
CYP1A2 P05177 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP3A4 P08684 2/20 0.36
CYP19A1 P11511 1/20 0.36
ADRB2 P07550 2/20 0.36
ADRB1 P08588 2/20 0.36
ADRB3 P13945 2/20 0.36
PORCN Q9H237 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL328856 0.91 HSD11B1 (1.00) HSD11B1HSD11B2LMNAALDH1A1MAPT
SCHEMBL328814 0.86 HSD11B1 (0.84) HSD11B1HSD11B2CYP2D6CYP1A2CYP2C9
SCHEMBL2827249 0.79 HSD11B1 (0.77) HSD11B1HSD11B2LMNAMAPTHTT
SCHEMBL2827245 0.79 HSD11B1 (0.77) HSD11B1HSD11B2LMNAMAPTHTT
SCHEMBL328841 0.77 HSD11B1 (1.00) HSD11B1HSD11B2CYP2D6CYP1A2CYP2C9
SCHEMBL328784 0.77 HSD11B1 (0.83) HSD11B1HSD11B2CYP2D6CYP2C9CYP3A4
SCHEMBL328911 0.75 HSD11B1 (0.49) HSD11B1HSD11B2LMNAALDH1A1HPGD
SCHEMBL328788 0.75 HSD11B1 (0.51) HSD11B1HSD11B2SMN1; SMN2HPGDHTT
SCHEMBL328942 0.68 HSD11B1 (0.86) HSD11B1HSD11B2CYP2D6CYP2C9CYP3A4
SCHEMBL4791837 0.68 HSD11B1 (1.00) HSD11B1HSD11B2CYP2D6CYP2C9CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2007719-B1 INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME ABBOTT LAB (US) 2012-05-02 EP disclosed
EP-2407452-A1 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme Abbott Laboratories (US) 2012-01-18 EP disclosed
US-7737137-B2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme ABBOTT LABORATORIES (US) 2010-06-15 US disclosed
US-20080312214-A1 Inhibitors of the 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Enzyme ABBOTT LABORATORIES (US) 2008-12-18 US disclosed
US-7435833-B2 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme ABBOTT LABORATORIES (US) 2008-10-14 US disclosed
US-20080076819-A1 INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME ABBOTT LABORATORIES (US) 2008-03-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080076819-A1 INHIBITORS OF THE 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1 ENZYME HSD11B1, HSD11B2, HSD17B1 HSD11B1 1/4885HSD11B2 2/4885LMNA 3653/4885
US-20080312214-A1 Inhibitors of the 11-Beta-Hydroxysteroid Dehydrogenase Type 1 Enzyme HSD11B1, HSD17B1, HSD11B2 HSD11B1 1/4885HSD11B2 3/4885LMNA 2073/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.